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Ethanol-Induced c-Fos Expression in Catecholamine-
and Neuropeptide Y-Producing Neurons
in Rat Brainstem
Todd E. Thiele, Inmaculada Cubero, Gertjan van Dijk, Cristina Mediavilla, and Ilene L. Bernstein
Background: Previous studies have used c-Fos-like immunoreactivity (cFLI) to examine the neuroana-
tomical location of cells that are activated in response to ethanol administration. However, the use of cFLI
alone fails to reveal the phenotypical identity of cells. In the present study we used double-labeling
procedures to identify the neurochemical phenotype of neurons that showed ethanol-induced cFLI in the
rat brainstem.
Methods: Individual groups of rats received intraperitoneal injection of ethanol (1.5 g/kg or 3.5 g/kg) or
isotonic saline (23 ml/kg). To assess the specificity of cFLI induced by ethanol, we injected other rats with
the drug lithium chloride (LiCl; 76 mg/kg). Two hours after injection, rats were killed and their brains were
processed for immunohistochemistry.
Results: Both doses of ethanol promoted cFLI in several brainstem regions, including the nucleus of the
solitary tract (NTS), the locus coeruleus (LC), and the ventrolateral medulla (VLM). Although LiCl caused
significant cFLI in the NTS, this drug promoted only minimal cFLI in the VLM and no significant activation
in the LC. We found that a significant proportion of tyrosine hydroxylase (TH)-positive neurons coex-
pressed ethanol-induced cFLI in the VLM (;75–85%), the NTS (;65–75%), and the LC (;30–65%).
Additionally, a significant proportion of neuropeptide Y (NPY)-producing neurons in the VLM coex-
pressed ethanol-induced cFLI (;60–75%). On the other hand, LiCl promoted activation of TH-positive
neurons in the VLM and the NTS but failed to stimulate cFLI in TH-producing neurons in the LC or in
NPY-producing neurons of the VLM.
Conclusions: Neurons in the rat brainstem that show ethanol-induced c-Fos expression produce cat-
echolamines and NPY. This research demonstrates the usefulness of double-labeling immunohistochem-
istry procedures for identifying the neurochemical identity of neurons that are activated after ethanol
administration.
Key Words: Alcohol, Locus Coeruleus, Neuropeptide Y, Norepinephrine, Ventrolateral Medulla.
IMMUNOSTAINING FOR c-Fos, the protein product ofthe immediate-early gene c-fos, is a useful technique for
examining neuronal activity (Morgan and Curran, 1991;
Sagar et al., 1988). In the absence of neuronal activation,
transcriptional activity of the c-fos gene in neurons is low,
with an associated lack of translation of active protein.
Because of the low baseline levels, increased c-Fos expres-
sion after stimulation can reveal the location of neuronal
activity. Over the past several years, c-Fos immunohisto-
chemistry has been used to identify neuronal sites activated
by ethanol administration. Ethanol-induced c-Fos-like im-
munoreactivity (cFLI) has been identified in several fore-
brain regions that include the bed nucleus of the stria
terminalis, the paraventricular nucleus of the thalamus and
hypothalamus, the central nucleus of the amygdala, and the
nucleus accumbens (Chang et al., 1995; Hitzemann and
Hitzemann, 1997; Ryabinin et al., 1997; Thiele et al., 1998b;
Zoeller and Fletcher, 1994). In the brainstem, ethanol-
induced cFLI has been observed in regions that include the
lateral parabrachial nucleus (PBN), the area postrema
(AP), the locus coeruleus (LC), and the nucleus of the
solitary tract (NTS) (Ryabinin et al., 1997; Thiele et al.,
1996, 1997, 1998b). These data suggest that ethanol stim-
ulates neuronal activation in multiple forebrain and brain-
stem regions.
Although cFLI has provided important information
about the neuroanatomical location of cells that are acti-
vated in response to ethanol administration, this technique,
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by itself, fails to reveal the phenotypical identity of acti-
vated cell populations. However, by labeling for cFLI and
specific neurotransmitters in the same tissue by using
double-labeling immunohistochemistry procedures, it is
possible to identify the neurochemical phenotype of cells
that show cFLI in response to drug administration (Hoff-
man et al., 1992, 1993; Matta et al., 1993, 1997). This is
possible because c-Fos protein is typically confined to the
cell nucleus whereas neurotransmitter is located in cyto-
plasm, thus making it possible to simultaneously visualize
both labeled proteins.
In the present study, we used double-labeling procedures
to begin characterizing cells that are activated by ethanol
administration in the brainstem. Previous research has in-
dicated that the catecholamine norepinephrine (NE) may
be involved in regulating voluntary ethanol ingestion and
the intoxicating effects that are produced by this drug
(Brown et al., 1977; Hodge et al., 1996; Lister et al., 1989;
Mao and Abdel-Rahman, 1996). Additionally, ethanol ad-
ministration has been found to increase synthesis, turnover,
and release of NE (Carlsson and Lindqvist, 1973; Corrodi
et al., 1966; Hunt and Majchrowicz, 1974; Karoum et al.,
1976; Pohorecky and Jaffe, 1975), and ethanol induces
cFLI in brainstem regions known to be populated by cat-
echolaminergic cells (i.e., the LC, ventrolateral medulla
[VLM], and NTS) (Cunningham and Sawchenko, 1988;
Palkovits et al., 1992; Riche et al., 1990; Zardetto-Smith
and Gray, 1990, 1995). Therefore, we assessed coexpression
of cFLI with tyrosine hydroxylase (TH) (the rate-limiting
enzyme in catecholamine biosynthesis) in the brainstem.
Furthermore, we examined coexpression of ethanol-
induced cFLI with neuropeptide Y (NPY), a neuropeptide
that is coexpressed with catecholamines in the brainstem
(Everitt et al., 1984; Sawchenko et al., 1985) and that
recently has been implicated in modulating sedative effects
produced by ethanol and voluntary ethanol consumption
(Ehlers et al., 1998; Hwang et al., 1999; Thiele et al.,
1998a).
Finally, as a control to assess specificity of ethanol-
induced cFLI, we also examined double labeling in animals
that were administered lithium chloride (LiCl). We used a
dose of LiCl that has been found to yield comparable
conditioned taste aversions and that has been shown to
cause cFLI induction in some of the same brainstem re-
gions as the largest dose of ethanol used in the present
study (Thiele et al., 1996).
METHODS
Animals
Subjects were male Long-Evans rats that weighed between 300 and
400 g and were individually housed in stainless steel cages on a 12 hr
light-dark cycle. Laboratory rat chow and water were provided ad libitum.
In an attempt to reduce stress-induced c-Fos induction, rats were accli-
mated to handling for approximately 2 weeks before the start of the
experiment. All procedures used in the present research were in compli-
ance with National Institutes of Health guidelines, and the protocols were
approved by the University of Washington Animal Care Committee.
Drug Administration
Different groups of rats were used for NPY and TH double-labeling
studies, and the studies were run at different times; however, the proce-
dures were identical and were as follows. On the test day, rats were
distributed to four groups equated for body weight (n 5 5 per group).
Each rat was removed from its cage, given an intraperitoneal injection of
drug, and then immediately returned to its cage. To assess potential
dose-dependent effects of ethanol on cFLI, we administered two doses of
ethanol: 1.5 g/kg or 3.5 g/kg, 15% (w/v) mixed in isotonic saline. As a
control, rats in a third group were given an injection of isotonic saline in
a volume equal to the largest dose of ethanol (23 ml/kg). Finally, a fourth
group of rats were given an injection of LiCl (76 mg/kg; 0.15 M). This dose
of LiCl and the largest dose of ethanol yield comparable saccharin aver-
sions after one-trial taste aversion conditioning and produce similar pat-
terns of cFLI in the brainstem (Thiele et al., 1996). Two hours after
injection, rats were anesthetized with Equithesin (3.3 ml/kg ip) and tran-
scardially perfused with isotonic phosphate-buffered saline (PBS) fol-
lowed by 4% paraformaldehyde in 0.1 M phosphate buffer. Brains were
removed and postfixed for approximately 48 hr and then were processed
for immunohistochemistry.
Immunohistochemistry Procedures
We cut 50 mm slices from the brainstem with a vibrotome in the coronal
plane. Tissue was collected just caudal to the AP (approximately 214.30
mm relative to bregma) and rostral through the LC (approximately
210.60 mm relative to bregma). Tissues were rinsed in PBS, incubated 20
min in 0.3% H2O2 in absolute menthol to quench endogenous peroxidase,
rinsed, and incubated 1 hr in 1% gelatin and 5% normal goat serum in
PBS. Slices were then transferred without rinsing to the primary antibody
solution (mixed in PBS) that consisted of 0.005 g/ml polyclonal rabbit
antiserum (Santa Cruz Biotechnology, Santa Cruz, CA; 1:20,000), which
recognizes residues 3 through 16 of the c-Fos protein. After approximately
48 hr of incubation at 4°C, slices were rinsed and processed by using the
ABC method (Vector Laboratories, Burlingame, CA). Slices were trans-
ferred to biotinylated goat antirabbit antibody for 1 hr, rinsed, transferred
to avidin-biotinylated peroxidase for 1 hr, rinsed again, and developed
with diaminobenzidine substrate intensified with nickel sulfate (6 min),
which produced dark blue-black cFLI nuclei. After an overnight rinse in
PBS, sections were run through a second assay. Sections from the NPY
study were incubated for 1 hr in 1% gelatin and 5% normal goat serum in
PBS, whereas sections from the TH study were incubated for 1 hr in 1%
gelatin and 5% normal horse serum in PBS. Sections were then trans-
ferred without rinsing to either rabbit anti-NPY (Sigma Chemical, St.
Louis, MO; 1:60,000) or mouse anti-TH (Sigma Chemical; 1:80,000). After
approximately 48 hr of incubation on ice (4°C), slices were rinsed and
transferred to either biotinylated goat antirabbit antibody (NPY study) or
biotinylated horse antimouse antibody (TH study) for 1 hr. Sections were
then rinsed and transferred to avidin-biotinylated peroxidase for 1 hr,
rinsed again, and developed in diaminobenzidine substrate without the
nickel sulfate (which produced light-brown cell bodies). Thus, double-
labeled cells were seen as dark blue-black nuclei surrounded by light-
brown cell bodies. Finally, slices were rinsed, mounted on slides, and
cover-slipped with Permount. As a control to assess potential nonspecific
staining in each assay, some sections were run through the assay either
without primary antibody (anti-NPY or anti-TH) or without secondary
antibody. Cell staining was absent when primary or secondary antibody
was omitted.
Scoring Immunohistochemistry and Data Analyses
Group treatments were masked on all slides during data quantification.
For each brain region examined, one section was scored per brain, and
care was taken so that structures were scored in approximately the same
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plane between brains. Camera lucida drawings were prepared in an area
of approximately 0.38 mm2 from c-Fos immunoreactive sections, in which
the number and location of c-Fos positive nuclei were recorded. Counts
were also made of neurotransmitter-positive cells (NPY or TH) and of
cells that coexpressed the c-Fos and neurotransmitter proteins. We used
analyses of variance (ANOVA) to analyze the cell count data and con-
ducted post hoc analyses by using Bonferroni tests. One-way ANOVAs
assessed differences between drug-treated groups (data collected from the
LC), whereas two-way ANOVAs assessed differences between drug treat-
ment at different brain regions through the caudal-rostral extent of the
brainstem (data collected from the NTS and VLM). For both cFLI data
and double-labeling data, the group injected with saline served as the
control comparison. In all cases, significance was accepted at p , 0.05
(two-tailed).
RESULTS
As reported previously (Thiele et al., 1996), ethanol-
induced cFLI was observed in the AP and the PBN; how-
ever, because significant double labeling was not observed
in these regions, these data are not presented. The pattern
of ethanol-induced cFLI did not differ between the NPY
and the TH studies, so only cFLI data from the TH study
are reported. Although NPY staining in the LC and the
NTS has been reported with immunohistochemistry proce-
dures (Everitt et al., 1984), the antibody we used in the
present study revealed NPY staining only in the VLM.
Ethanol-Induced cFLI and Double Labeling With TH and
NPY in the VLM
Drug-induced cFLI in the VLM is presented in Fig.
1A. Both the 1.5 g/kg and 3.5 g/kg doses of ethanol
induced significant cFLI relative to the saline injection
throughout the caudal-rostral extent of the VLM, in both
the noradrenergic A1 (caudal) and adrenergic C1 (ros-
tral) subregions. Furthermore, the 3.5 g/kg dose of eth-
anol induced significantly greater c-Fos expression than
the 1.5 g/kg dose, which indicated a dose-response effect.
However, when compared with the saline injection, LiCl
promoted significant cFLI only at 213.80 mm relative to
bregma. ANOVA on the data revealed a significant drug
treatment effect [F(3,16) 5 51.81], a significant brain
regions effect [F(3,48) 5 27.61], and a significant inter-
action between these variables [F(9,48) 5 2.46]. A Bon-
ferroni test confirmed the individual group differences.
Double-labeling data of cFLI with TH in the VLM are
presented in Fig. 1B, and photomicrographs representa-
tive of these data are in Fig. 2A through 2 C. When
compared with the saline injection, both doses of ethanol
caused cFLI in a significant percentage of TH-producing
cells throughout the entire extent of the VLM, and there
were no significant differences between the two ethanol-
treated groups. LiCl induced significant levels of cFLI in
TH-producing cells near the caudal end of this brainstem
region. At 214.30 mm and 213.80 mm relative to
bregma, ;75% to 85% of the TH-positive cells coex-
pressed ethanol-induced cFLI. In this same region, dou-
ble labeling was seen in ;35% to 55% of the TH-positive
cells after LiCl injection. ANOVA revealed a significant
drug treatment effect [F(3,16) 5 110.55] and a signifi-
cant brain regions effect [F(3,48) 5 18.17]. A Bonferroni
test confirmed the group differences. A slightly different
pattern of coexpression emerged with the NPY data (Fig.
1C and Fig. 2D through 2F). Both doses of ethanol
induced cFLI in a significant number of NPY-positive
cells throughout the entire VLM (;60 –75% coexpres-
sion in the caudal region) relative to the saline treat-
ment, and there were no significant differences between
the ethanol-treated groups. However, LiCl completely
failed to promote any significant level of coexpression.
ANOVA was significant and showed a significant drug
treatment effect [F(3,16) 5 26.04] and a significant brain
regions effect [F(3,48) 5 4.28]. A Bonferroni test run on
the data confirmed the conclusions.
Fig. 1. Data collected through the VLM at various points relative to bregma
after intraperitoneal injection of drug. Sal, saline (23 ml/kg); LiCl, lithium chloride
(76 mg/kg); E1.5, ethanol (1.5 g/kg); E3.5, ethanol (3.5 g/kg). (A) Mean (6SEM)
cFLI nuclei in the VLM. (B) Mean (6SEM) percentage of TH-producing neurons in
the VLM that coexpress drug-induced cFLI. (C) Mean (6SEM) percentage of
NPY-producing neurons in the VLM that coexpress drug-induced cFLI. * Signif-
icant at p , 0.05 relative to the saline-injected group (sal).
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Ethanol-Induced cFLI and Double Labeling With TH in
the NTS
Drug-induced cFLI in the NTS is presented in Fig. 3A.
Relative to saline injection, both doses of ethanol and
LiCl induced significant cFLI in this A2 (noradrenergic)
region of the NTS, and these three groups did not differ
significantly. ANOVA revealed a significant drug treat-
ment effect [F(3,16) 5 5.25] and a significant brain
regions effect [F(1,16) 5 6.98]. Data that show double
labeling of cFLI with TH in the NTS are presented in
Fig. 3B, and representative photomicrographs through
the NTS are presented in Fig. 4A through 4C. When
compared with the saline treated group, in the most
caudal aspect of the A2 region (214.30 mm relative to
bregma) ethanol promoted a significant level of cFLI in
TH-producing cells (;20% coexpression), whereas sig-
nificant coexpression was caused by both ethanol (;65–
75% of TH-positive cells) and LiCl (;50% of TH-
positive cells) at 213.80 mm relative to bregma. There
were no significant differences between the LiCl- and
ethanol-treated groups. ANOVA on the double-labeling
data revealed a significant drug treatment effect
[F(3,16) 5 13.08], a significant brain regions effect
[F(1,16) 5 35.15], and a significant interaction between
the variables [F(3,16) 5 3.85]. Post hoc tests confirmed
the conclusions.
Ethanol-Induced cFLI and Double Labeling With TH in
the LC
Data showing drug-induced cFLI in the LC are pre-
sented in Fig. 5A. As with the VLM and NTS, when com-
pared with the saline treatment, both doses of ethanol
caused significant induction of cFLI in the LC, at approx-
imately 210.60 mm relative to bregma. Furthermore, the
3.5 g/kg dose of ethanol promoted significantly greater
Fig. 2. Representative photomicrographs of coronal slices through the VLM (4003 magnification was used for all photomicrographs). Slices show double labeling
of TH-producing neurons with drug-induced cFLI (A, B, and C) and NPY-producing neurons with drug-induced cFLI (D, E, and F). Sections in the left column are from
animals given intraperitoneal injection of 3.5 g/kg ethanol (A and D), sections in the middle column are from animals given intraperitoneal injection of LiCl (B and E),
and sections in the right column are from animals given intraperitoneal injection of saline (C and F). The VLM is approximately 213.80 mm relative to bregma. Dark
brown-black spots are cFLI nuclei, which are often found within light-brown cell bodies. Arrows indicate examples of coexpression of cFLI with TH- or NPY-
immunoreactivity.
Fig. 3. Data collected through the caudal aspect of the NTS at various points
relative to bregma after intraperitoneal injection of drug. (A) Mean (6SEM) cFLI
nuclei in the NTS. (B) Mean (6SEM) percentage of TH-producing neurons in the
NTS that coexpress drug-induced cFLI. * Significant at p , 0.05 relative to the
saline-injected group (sal).
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cFLI than the 1.5 g/kg dose in this region. On the other
hand, LiCl injection failed to promote cFLI in the LC.
ANOVA run on LC data attained statistical significance
[F(3,16) 5 6.99], and a Bonferroni test confirmed the
individual group differences. Data that depict double label-
ing of cFLI with TH in the LC are presented in Fig. 5B, and
representative photomicrographs through the LC are pre-
sented in Fig. 4D through 4F. Relative to the saline group,
there was significant coexpression (;30–65%) of ethanol-
induced cFLI with TH in the LC, and the two ethanol
treated groups differed significantly from each other, which
indicated a dose-response effect. However, because there
was no significant induction of cFLI in this region by LiCl,
coexpression was not possible. ANOVA performed on the
double-labeling data from the LC was significant
[F(3,16) 5 27.51], and the post hoc test confirmed the
group differences.
DISCUSSION
Consistent with previous research (Ryabinin et al., 1997;
Thiele et al., 1996, 1997, 1998b), ethanol caused dose-
dependent cFLI in several brainstem regions, including the
NTS (Fig. 3A) and the LC (Fig. 5A), as well as the AP and
PBN (data not shown). Additionally, we found that ethanol
caused robust cFLI through the caudal-rostral extent of the
VLM (Fig. 1A). Interestingly, c-Fos induction in the LC
was limited to ethanol injection, with no significant cFLI
observed in this region following LiCl injection.
The main goal of this research was to characterize the
neurochemical phenotype of cells in the brainstem that are
activated by ethanol administration. Two distinct cell pop-
ulations have been identified in the VLM: a noradrenergic
cell group at the caudal end (A1 group) and an adrenergic
cell group that begins rostral to the obex (C1 group) (Kalia
et al., 1985a, 1985b; Tucker et al., 1987). NPY is colocalized
with catecholaminergic neurons of both groups. Addition-
ally, the catecholamine NE and NPY are produced in the
LC (A6 group) and in the NTS (A2 group) (Everitt et al.,
1984). Thus, we assessed coexpression of drug-induced
Fig. 4. Representative photomicrographs of coronal slices through the NTS (A, B, and C) and the LC (D, E, and F) show double labeling of TH-producing neurons
with drug-induced cFLI (4003 magnification was used for all photomicrographs). Sections in the left column are from animals given intraperitoneal injection of 3.5 g/kg
ethanol (A and D), sections in the middle column are from animals given intraperitoneal injection of LiCl (B and E), and sections in the right column are from animals
given intraperitoneal injection of saline (C and F). The NTS is approximately 213.80 mm relative to bregma, and the LC is approximately 210.60 mm relative to bregma.
Dark brown-black spots are cFLI nuclei, which are often found within light-brown cell bodies. Arrows indicate examples of coexpression of cFLI with TH-
immunoreactivity.
Fig. 5. Data collected from the LC after intraperitoneal injection of drug. (A)
Mean (6SEM) cFLI nuclei in the LC. (B) Mean (6SEM) percentage of TH-
producing neurons in the LC that coexpress drug-induced cFLI. * Significant at
p , 0.05 relative to the saline-injected group (sal).
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cFLI with TH- or NPY-immunoreactivity in these brain-
stem regions. A significant percentage of TH-
immunoreactive cells in the VLM coexpressed cFLI after
ethanol injection, with highest levels of coexpression at
;75% to 85% in the caudal VLM (Fig. 1B). Similarly,
ethanol injection promoted cFLI in a significant proportion
of TH-positive neurons in the caudal NTS (Fig. 3B; ;65–
75% coexpression) and in the LC (Fig. 5B; ;30–65%
coexpression). On the other hand, although LiCl-injection
was associated with a high proportion of TH-producing
neurons that were c-Fos positive in the VLM (;35–55%)
and the NTS (;50%), LiCl completely failed to stimulate
significant cFLI in TH-positive cells in the LC.
We found that a large proportion of NPY-producing
cells in the VLM coexpressed ethanol-induced cFLI (Fig.
1C; ;60–75% coexpression in the caudal VLM). In con-
trast, LiCl injection failed to stimulate any significant cFLI
in NPY-producing neurons in the VLM. Together, these
data suggest that catecholamine- and NPY-producing neu-
rons in the brainstem are activated in response to ethanol
administration. Importantly, these data provide the first
evidence that ethanol administration activates neurons that
produce NPY. Activation of catecholaminergic neurons in
the LC and NPY neurons in the VLM was specific to
ethanol administration, because LiCl failed to stimulate
cFLI in these cell groups. On the other hand, LiCl and
ethanol administration produced similar patterns of cFLI
in catecholaminergic cells in the NTS and in the caudal
aspect of the VLM. We have shown previously that LiCl,
ethanol, and tastes that have become aversive by virtue of
their association with these drugs activate neurons in the
NTS, a region hypothesized to play a role in conditioned
taste aversion learning (Thiele et al., 1996). Given the
importance of the NTS in taste aversion learning, the
present data suggest that activation of catecholaminergic
cells in the NTS may be a cellular response to the aversive
effects of ethanol and the toxin LiCl. The similar activation
of catecholaminergic cells in the caudal VLM by LiCl and
by ethanol suggests that these cells may also respond to the
aversive effects caused by these drugs.
The present report and previous studies have found ro-
bust cFLI in the LC after ethanol administration (Ryabinin
et al., 1997; Thiele et al., 1997, 1998b), which suggests that
ethanol stimulates neuronal activity in this brain region.
However, although evidence for ethanol-induced stimula-
tion of LC neurons also has been found by using local
glucose utilization as a measure of neuronal activity
(Williams-Hemby et al., 1996), others have found that eth-
anol administration is associated with inhibition of neuro-
nal activity in the LC (Aston-Jones et al., 1982; Pohorecky
and Brick, 1977; Strahlendorf and Strahlendorf, 1983). A
possible explanation for this apparent discrepancy is that
ethanol-induced cFLI is located in inhibitory
g-aminobutyric acid (GABA) intraneurons located within
the LC (Iijima et al., 1988; Van Bockstaele, 1998). Thus,
ethanol may activate GABA cells in the LC, which in turn
contributes to a general inhibition of neuronal activity in
this region. At odds with this explanation, however, is our
observation that ethanol-induced cFLI is found in TH-
positive neurons. Previous reports indicate that tyrosine
hydroxylase and GABA are not expressed in the same
neurons within the LC (Van Bockstaele, 1998). A second
explanation is based on evidence of cellular inhibition in
the LC via recurrent axonal collaterals (Aghajanian et al.,
1977; Egan et al., 1983). It is possible that catecholaminer-
gic cells in the LC are initially activated by ethanol admin-
istration, which induces c-Fos expression. Initial activation
of catecholaminergic cells may be followed by inhibition
caused by inhibitory recurrent axonal collaterals from the
same cells (Aghajanian et al., 1977; Egan et al., 1983). This
could explain evidence of ethanol-induced c-Fos expres-
sion, and inhibition of neuronal activity by ethanol, in the
LC.
It is of interest to speculate on the possible role that
catecholamines and NPY play in mediating neurobiological
responses to ethanol. We have found that mutant mice that
lack NPY show high levels of ethanol consumption and are
resistant to ethanol-induced sedation. On the other hand,
transgenic mice that overexpress NPY were found to drink
little ethanol and had increased sensitivity to the sedative
effects of this drug (Thiele et al., 1998a). These data sug-
gest that ethanol consumption and resistance to the acute
effects of ethanol are inversely related to central NPY
levels. Other evidence that suggests a role for NPY in
mediating ethanol consumption comes from rats that have
been selectively bred for high and low ethanol intake, that
is, the Indiana alcohol-preferring (AP) and alcohol-
nonpreferring (NP) lines, respectively (Li et al., 1993).
Quantitative trait locus analyses run on these rats suggested
that line differences in ethanol intake may be modulated by
the NPY gene (Carr et al., 1998). Furthermore, NPY levels
were found to be low in several brain regions of the AP rats,
including the central nucleus of the amygdala (CeA)
(Ehlers et al., 1998; Hwang et al., 1999). More recently, the
selectively bred high alcohol-drinking (HAD) rats also
were found to have abnormally low levels of NPY in the
CeA (Hwang et al., 1999). Thus, there is increasing evi-
dence that NPY may be involved with regulating ethanol-
seeking behavior and the acute effects that are produced by
this drug.
The present data suggest an additional role for NPY by
showing that ethanol treatment stimulates activity of cells
that contain NPY, which indicates that ethanol may stim-
ulate central NPY activity. It will be important to deter-
mine if ethanol administration promotes synthesis and/or
synaptic release of NPY in the central nervous system.
Interestingly, NPY-producing neurons in the VLM have
been shown to project to the CeA (Zardetto-Smith and
Gray, 1995). It is tempting to speculate that ethanol-
induced activation of NPY neurons in the VLM causes
synaptic release of this neuropeptide in the CeA, perhaps
serving as a mechanism to prevent overconsumption of
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ethanol. High alcohol-consuming rats (AP and HAD),
which show low levels of NPY in the CeA, may have
abnormally low ethanol-stimulated NPY activity, which
promotes increased consumption of this drug.
Consistent with the present results, acute administration
of ethanol has been found to increase synthesis, turnover,
and release of NE, which suggests an important role for this
catecholamine in regulating the neurobiological effects of
ethanol (Carlsson and Lindqvist, 1973; Corrodi et al., 1966;
Hunt and Majchrowicz, 1974; Karoum et al., 1976; Po-
horecky and Jaffe, 1975). Although chemical-induced le-
sions of NE-producing cells have produced conflicting re-
sults (Kiianmaa, 1980; Melchior and Myers, 1976; Myers
and Melchior, 1975; Richardson and Novakovski, 1978),
blocking conversion of dopamine to NE with dopamine
b-hydroxylase inhibitors has been found to reduce ethanol
consumption in rats (Brown et al., 1977), and infusion of
NE into the paraventricular nucleus of the hypothalamus
(PVN) has been found to increase ethanol consumption in
rats (Hodge et al., 1996). NE-producing neurons from the
VLM, the NTS, and the LC all provide projections to the
PVN (Cunningham and Sawchenko, 1988; Palkovits et al.,
1992; Riche et al., 1990). Thus, in light of the present
results, it is possible that activation of brainstem neurons
after consumption of alcohol causes synaptic release of NE
into the PVN, which may promote continued ingestion of
this drug.
In addition to its involvement in ethanol-seeking behav-
ior, there is evidence that NE may be involved with acute
effects that are produced by ethanol. For example, antag-
onists of the a2 adrenoreceptors attenuate the sedative
effects associated with ethanol administration, whereas a2
agonists potentiate ethanol-induced sedation (Lister et al.,
1989; Mao and Abdel-Rahman, 1996). Thus, NE activity in
response to ethanol may contribute to the intoxicating
effects of this drug. Additionally, ethanol administration
causes vasodilation and dramatically reduces blood pres-
sure (El-Mas and Abdel-Rahman, 1999; Gillespie, 1967).
NE promotes vasoconstriction (Taylor et al., 1999), and
catecholaminergic projections from the VLM to the fore-
brain have been implicated in blood pressure regulation
(Saper et al., 1983). Thus, it is possible that activation of
catecholaminergic neurons in the VLM may represent sym-
pathetic activity that serves as a compensatory mechanism
against vasodilation and altered blood pressure produced
by ethanol administration.
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